Roche raise sales expectations
May 12, 2005Sales and Marketing
Roche has raised its full-year sales forecast after strong first quarter results saw the Swiss company outperform a number of …
Monoclonal antibody sales set to rocket
May 12, 2005Sales and Marketing
The monoclonal antibody market will treble in size to $30 billion by 2010, according to a report by analysts Datamonitor.Datamonitor …
Novartis files novel iron overload treatment
May 12, 2005Sales and Marketing
A new treatment for the rare and difficult to treat condition of chronic iron overload has been filed by Novartis …
FDA approves Requip for restless legs syndrome
May 12, 2005Sales and Marketing
GlaxoSmithKline's Requip has become the first medicine to receive US approval for the treatment of restless legs syndrome (RLS), after …
Increasing salesforce effectiveness
May 11, 2005Sales and Marketing
Pfizer will cut costs worth $4 billion over the next three years in an attempt to return to double-digit earnings …
10 Brand Blunders…And How to Avoid Them
May 10, 2005Sales and Marketing
1) Stay loyal to the core brand message and never undermine itIt may have seemed a good idea at the …
Stepping out: the contract salesforce
May 10, 2005Sales and Marketing
Sales forces in the pharmaceutical industry account for around 75% of marketing budgets, and are coming under increasing pressure to …
Gilmartin to leave troubled Merck
May 6, 2005Sales and Marketing
Raymond Gilmartin has stood down as chief executive and chairman of Merck, drawing a line under long-running uncertainty regarding the …
GSK makes strategic biotech acquisition
May 6, 2005Research and Development, Sales and Marketing GSK, biotech
GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
Crestor sales top $1 billion for AstraZeneca
May 6, 2005Sales and Marketing
AstraZeneca's Crestor has achieved blockbuster status, despite continuing concerns over its safety, registering sales of over $1 billion for the …
Lilly’s first-in-class diabetes drug approved in US
May 5, 2005Sales and Marketing
Lilly has gained US marketing approval for Byetta, the first in a new class of type II diabetes treatments derived …
Mixed news for AstraZeneca’s stroke drug Cerovive
May 4, 2005Research and Development, Sales and Marketing
AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …
Does your brand need a check-up?
May 4, 2005Sales and Marketing
Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …
Filling in the gaps in your team
May 4, 2005Business Services
Outsourcing as an integral element of a business strategy has waxed and waned in popularity and acceptability over the last …
Taking on the market leader
May 4, 2005Sales and Marketing
Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …
Velcade moves up to second line treatment
April 28, 2005Sales and Marketing
Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …
EMEA advises against prescribing of antidepressants in children
April 28, 2005Sales and Marketing
Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
Latest content
FibroFind appoints Lee Borthwick as CEO
